VTRS Q3 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.0B+3.5% YoY

Gross Profit

$1.1B36.2% margin

Operating Income

$324M10.9% margin

Net Income

$190M6.4% margin

EPS (Diluted)

$0.37

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

$488M

Free Cash Flow

$445M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$31.1B

Total Liabilities

$19.6B

Stockholders' Equity

$11.5B

Cash & Equivalents

$359M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$2.9B	+3.5%
Gross Profit	$1.1B	$1.0B	+3.2%
Operating Income	$324M	$338M	-4.3%
Net Income	$190M	$177M	+7.4%